HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002.
about
State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectivenessA complex systems approach to evaluate HIV prevention in metropolitan areas: preliminary implications for combination intervention strategiesCost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug usersMetropolitan social environments and pre-HAART/HAART era changes in mortality rates (per 10,000 adult residents) among injection drug users living with AIDSTrends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007A Cost Analysis of Hospitalizations for Infections Related to Injection Drug Use at a County Safety-Net Hospital in Miami, FloridaRisk Environments, Race/Ethnicity, and HIV Status in a Large Sample of People Who Inject Drugs in the United StatesField-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA.Use of Medicaid data to explore community characteristics associated with HIV prevalence among beneficiaries with schizophrenia.Health and oral health care needs and health care-seeking behavior among homeless injection drug users in San Francisco.Group sex events amongst non-gay drug users: an understudied risk environment.Examining delay discounting of condom-protected sex among opioid-dependent women and non-drug-using control womenLinkage to care for HIV-infected heterosexual men in the United StatesIncreased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug usersPrevention and treatment produced large decreases in HIV incidence in a model of people who inject drugs.Female and male differences in AIDS diagnosis rates among people who inject drugs in large U.S. metro areas from 1993 to 2007.Correlates of HIV testing and receipt of test results in addiction health services in Los Angeles County.Comparison of Rapid Point-of-Care Tests for Detection of Antibodies to Hepatitis C Virus.A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs.Estimating the Size of the MSM Population in Metro Vancouver, Canada, Using Multiple Methods and Diverse Data Sources.Cost-Effectiveness of Frequent HIV Testing of High-Risk Populations in the United States.Low Rates of Adoption and Implementation of Rapid HIV Testing in Substance Use Disorder Treatment Programs.Attitudes toward methadone among out-of-treatment minority injection drug users: implications for health disparities.Perceived susceptibility to AIDS predicts subsequent HIV risk: a longitudinal evaluation of jail inmates.Modeling a dynamic bi-layer contact network of injection drug users and the spread of blood-borne infections.Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs.Income inequality, drug-related arrests, and the health of people who inject drugs: Reflections on seventeen years of researchRapid diagnostic HCV antibody assays.Associations of place characteristics with HIV and HCV risk behaviors among racial/ethnic groups of people who inject drugs in the United States.Acute HIV infection transmission among people who inject drugs in a mature epidemic setting.Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.Cost-effectiveness of interventions to prevent HIV and STDs among women: a randomized controlled trial.The Effectiveness of the Harm Reduction Group Therapy Based on Bandura's Self-Efficacy Theory on Risky Behaviors of Drug-Dependent Sex Worker Women.
P2860
Q28255620-5D96295F-5FF6-4584-B14C-EC4227CF9E71Q28483747-4D458946-C2AC-4D32-B1C6-34F7D97D3939Q28483820-0D1E77B5-5CAA-423D-96A7-6C2ADD5F2482Q28486380-F64B9224-BC86-4C4E-892B-C56FCB4DC038Q28533642-47AE8FBA-E3A4-41F0-838C-03B218C46922Q28548379-7F117BC4-19DF-4970-AD52-57BE9A21BCB8Q28550727-491E679E-D161-4E23-9228-49A6011FE910Q33834953-4EF5DD97-8126-4645-B84D-189530A2DBC7Q33991523-8974A143-871C-4140-B344-9640107ADF52Q34420194-7DBD9AD0-4893-4BA3-AB9B-3526EF79A11BQ34482237-3C51E81A-DAEF-4600-8716-63BB52B33911Q34614145-A6F00EBC-E9D1-4E06-A80D-3FB4BE5402AAQ35019900-F51C6A57-E302-43AC-8672-E71555519607Q35660526-6DD31F92-11F3-4F38-9AB0-53B853EEEBFEQ35749923-7D665D1F-4B9B-4876-B232-C82C95623C56Q35751758-8B193FEB-4A18-4DCC-87A5-C77B224B88F4Q35923004-480E6553-8EC2-4FF3-9ED4-8CAE77279B23Q35935659-A776E3BE-3B5D-40F5-A896-25359C74A80FQ35981674-8D004E98-7730-4C2A-9969-0B0F53A1156BQ36409955-0AE9BF1F-AE44-422E-8C99-06456CD06478Q36628388-76412175-0C0B-4830-B441-6AFB7545B345Q36642977-B74AEB5D-8474-4AB1-AABA-CA06B5B803B3Q37167220-D05511FD-981D-4D8F-AF78-823E4F979E35Q37185138-8139E205-B937-47E4-9724-8239042AF61EQ37499070-5EC2C5B9-F160-440B-98A9-12B1FA4AF0BCQ37661224-DF341636-A955-4321-98E6-DB51E42AFA0DQ37691641-12CE050D-F525-42D9-882B-030B60569CD8Q38074389-BF0FE57D-B3FE-4E8F-9330-834FFAA82979Q38826295-9D449058-EE02-4988-ACB2-FB9083D4D48DQ40503118-C264B9D6-57CB-4476-8ED3-F9CEE8250E3EQ43040568-35718D23-3A8E-4AE7-9B57-53C0052D691BQ44310198-A5E80BB1-850C-48A4-92AD-644B6676B532Q53410277-66C7A44A-8E22-4564-AECB-1A99C25C5565
P2860
HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
HIV prevalence rates among inj ...... metropolitan areas, 1992-2002.
@en
HIV prevalence rates among inj ...... metropolitan areas, 1992-2002.
@nl
type
label
HIV prevalence rates among inj ...... metropolitan areas, 1992-2002.
@en
HIV prevalence rates among inj ...... metropolitan areas, 1992-2002.
@nl
prefLabel
HIV prevalence rates among inj ...... metropolitan areas, 1992-2002.
@en
HIV prevalence rates among inj ...... metropolitan areas, 1992-2002.
@nl
P2093
P2860
P1476
HIV prevalence rates among inj ...... metropolitan areas, 1992-2002.
@en
P2093
Barbara Tempalski
Charles M Cleland
Hannah Cooper
Joanne E Brady
Samuel R Friedman
Spencer Lieb
P2860
P2888
P304
P356
10.1007/S11524-008-9328-1
P577
2008-11-18T00:00:00Z